Bowman Consulting Group Ltd. <BWMN.O>: JP Morgan cuts to Underweight from Neutral; raises target price to $43 from $40
BWMN•Related News
Emergent BioSolutions Inc. <EBS.N>: JP Morgan resumes coverage with Underweight rating
EBS•
FOREX-Dollar wobbles as investors balk at US Treasury's rescue efforts
TLT•
Viridian Therapeutics Chief Legal Officer Jennifer Tousignant disposes of common shares worth $348,194
VRDN•
Faraday Future presents EAI robotics strategy at 2026 J.P. Morgan Auto Conference in New York
FFAI•
WISeKey appoints Alexander Hirsch as group chief marketing officer
WKEY•